Folotyn, also known as pralatrexate, is a medication used in the treatment of a type of cancer called peripheral T-cell lymphoma (PTCL). This drug belongs to a class of medications known as antifolate agents, which work by interfering with the growth and spread of cancer cells in the body.

Folotyn is typically administered as an injection into a vein by a healthcare professional in a clinical setting. The dosage and frequency of administration will be determined by your healthcare provider based on your individual condition and response to treatment.

It is important to follow your healthcare provider’s instructions carefully when taking Folotyn to ensure the best possible outcome. Like all medications, Folotyn may cause side effects, which can vary from person to person. Common side effects may include nausea, vomiting, fatigue, and decreased appetite. It is important to report any side effects to your healthcare provider promptly so that they can be managed effectively.

Before starting treatment with Folotyn, it is important to inform your healthcare provider about any other medications or supplements you are taking, as well as any medical conditions you may have. This will help to prevent any potential interactions or complications.

Overall, Folotyn is an important medication in the treatment of PTCL and can help to improve outcomes for patients with this type of cancer. If you have been prescribed Folotyn, be sure to discuss any questions or concerns with your healthcare provider to ensure that you are receiving the best possible care.